Ken Griffin Bio Rad Laboratories, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 10,600 shares of BIO stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,600
Previous 11,000
3.64%
Holding current value
$2.43 Million
Previous $3.61 Million
28.56%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$438 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$359 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$355 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$209 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$201 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.64B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...